Titre :

Safety and Efficacy of an AIEC-targeted Bacteriophage Cocktail in a Mice Colitis Model.

Auteur(s) :

Titecat, Marie [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Rousseaux, Christel [Auteur]
Institut de biologie de Lille - UMS 3702 [IBL]
Dubuquoy, Caroline [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Foligne, Benoit [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Rahmouni, Oumaira [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Mahieux, Séverine [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Desreumaux, Pierre [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Woolston, Joelle [Auteur]
Sulakvelidze, Alexander [Auteur]
Wannerberger, Kristin [Auteur]
Neut, Christel [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Titre de la revue :

Journal of Crohn's and Colitis

Nom court de la revue :

J Crohns Colitis

Numéro :

16

Pagination :

1617–1627

Date de publication :

2022-08-24

ISSN :

1876-4479

Mot(s)-clé(s) en anglais :

Bacteriophages
AIEC
colitis

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Background and aims Adherent invasive Escherichia coli [AIEC] are recovered with a high frequency from the gut mucosa of Crohn’s disease patients and are believed to contribute to the dysbiosis and pathogenesis of this ...
Lire la suite >Background and aims Adherent invasive Escherichia coli [AIEC] are recovered with a high frequency from the gut mucosa of Crohn’s disease patients and are believed to contribute to the dysbiosis and pathogenesis of this inflammatory bowel disease. In this context, bacteriophage therapy has been proposed for specifically targeting AIEC in the human gut with no deleterious impact on the commensal microbiota. Methods The in vitro efficacy and specificity of a seven lytic phage cocktail [EcoActive™] was assessed against [i] 210 clinical AIEC strains, and [ii] 43 non-E. coli strains belonging to the top 12 most common bacterial genera typically associated with a healthy human microbiome. These data were supported by in vivo safety and efficacy assays conducted on healthy and AIEC-colonized mice, respectively. Results The EcoActive cocktail was effective in vitro against 95% of the AIEC strains and did not lyse any of the 43 non-E. coli commensal strains, in contrast to conventional antibiotics. Long-term administration of the EcoActive cocktail to healthy mice was safe and did not induce dysbiosis according to metagenomic data. Using a murine model of induced colitis of animals infected with the AIEC strain LF82, we found that a single administration of the cocktail failed to alleviate inflammatory symptoms, while mice receiving the cocktail twice a day for 15 days were protected from clinical and microscopical manifestations of inflammation. Conclusions Collectively, the data support the approach of AIEC-targeted phage therapy as safe and effective treatment for reducing AIEC levels in the gut of IBD patients.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Date de dépôt :

2024-01-12T00:47:15Z
2024-01-30T13:32:08Z